Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Poch

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
BMC Anesthesiology|November 5, 2018
Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral centerJuan Chipollini, Brandon Alford, David C Boulware, et al.
Urology|April 5, 2016
Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical PracticeAdam M Luchey, Neil J Manimala, Shohreh Dickinson, et al.
BJU International|March 18, 2015
Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohortJared M Gopman, Rosa S Djajadiningrat, Adam S Baumgarten, et al.
European Urology Focus|December 20, 2025
Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial DesignSeyed Behzad Jazayeri, Renzo G DiNatale, Christopher Guske, et al.
World Journal of Surgery|May 12, 2018
Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care CenterSephalie Y Patel, Rosemarie E Garcia Getting, Brandon Alford, et al.
The Prostate|January 3, 2013
The association between calcium channel blocker use and prostate cancer outcomeMichael A Poch, Diana Mehedint, Dawn J Green, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapyTobin J Strom, Richard B Wilder, Daniel C Fernandez, et al.
JAMA Oncology|September 5, 2018
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder CancerCharles C Peyton, Dominic Tang, Richard R Reich, et al.
European Urology|March 8, 2020
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-GuérinRoger Li, Debasish Sundi, Jingsong Zhang, et al.
Urologic Oncology|July 10, 2022
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancerAhmet Murat Aydin, Salim K Cheriyan, Richard Reich, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
BMC Anesthesiology|November 5, 2018
Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral centerJuan Chipollini, Brandon Alford, David C Boulware, et al.
Urology|April 5, 2016
Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical PracticeAdam M Luchey, Neil J Manimala, Shohreh Dickinson, et al.
BJU International|March 18, 2015
Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohortJared M Gopman, Rosa S Djajadiningrat, Adam S Baumgarten, et al.
European Urology Focus|December 20, 2025
Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial DesignSeyed Behzad Jazayeri, Renzo G DiNatale, Christopher Guske, et al.
World Journal of Surgery|May 12, 2018
Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care CenterSephalie Y Patel, Rosemarie E Garcia Getting, Brandon Alford, et al.
The Prostate|January 3, 2013
The association between calcium channel blocker use and prostate cancer outcomeMichael A Poch, Diana Mehedint, Dawn J Green, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapyTobin J Strom, Richard B Wilder, Daniel C Fernandez, et al.
JAMA Oncology|September 5, 2018
Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder CancerCharles C Peyton, Dominic Tang, Richard R Reich, et al.
European Urology|March 8, 2020
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-GuérinRoger Li, Debasish Sundi, Jingsong Zhang, et al.
Urologic Oncology|July 10, 2022
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancerAhmet Murat Aydin, Salim K Cheriyan, Richard Reich, et al.
Pageof 6